EU General Court Backs European Commission in Refusal to Approve Schizophrenia Medicine
- 24/12/2019
- Articles
Please find attached short comments on a judgment which the EU’s General Court handed down on 19 December 2019. The judgment confirms the broad discretionary powers of the European Commission and the European Medicines Agency when handling a request for marketing authorisation of a medicine under the centralised procedure.